Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms

December 7, 2015 updated by: Mark A. Lumley, Wayne State University
The goal of this study is to test the feasibility and acceptability of providing an experiential assessment interview that targets emotional and stressful experiences in primary care. In this randomized, controlled trial, the investigators will compare an interview condition to a wait-list control condition. The investigators hypothesize that helping individuals first identify the links between their stress and symptoms will likely increase their awareness and endorsement of the link between stress and physical symptoms, including a willingness to engage in stress management techniques. It is also expected that helping raise an individual's awareness about their symptoms, followed by an experience and expression of unexpressed emotions is likely to influence their physical symptoms and psychological status.

Study Overview

Status

Completed

Detailed Description

Emotional stress, particularly when a patients inhibits their experiences and feelings, contributes to physical symptoms. However, primary care patients with medically unexplained symptoms are rarely assessed for the stress and emotions in an comprehensive manner. The goal of this study is to test the feasibility and acceptability of providing an experiential assessment interview that targets emotional and stressful experiences in primary care with medically unexplained physical symptoms. In this randomized, controlled trial, the investigators will compare an interview condition to a wait-list control condition. The interview will review patients health history, psychosocial history, make links between the two, and help patients identify and express emotions related to conflicts or victimization. The investigators hypothesize that helping individuals first identify the links between their stress and symptoms will likely increase their awareness and endorsement of the link between stress and physical symptoms, including a willingness to engage in stress management techniques. It is also expected that helping raise an individual's awareness about their symptoms, followed by an experience and expression of unexpressed emotions is likely to influence their physical symptoms and psychological status.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Rochester Hills, Michigan, United States, 48307
        • Wayne State University Family Medicine Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must score above 10 (moderate range) on the Patient Health Questionnaire-15, which is a measure of a range of medical symptoms that are often medically unexplained.

Exclusion Criteria:

  1. Conditions that could interfere with the interview:

    • non-English speaking
    • psychosis
    • dementia
    • mental impairment
  2. The presence of disease or injury that could account for the physical symptoms. - Examples: autoimmune disease, bodily injury, serious infection, cancer, heart disease, COPD, post-stroke.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stress and Health Interview
Stress and Health Interview is an experiential assessment technique
A stress and health interview which aims to help patients: a) disclose their stressful experiences and emotional conflicts, which might be contributing to their symptoms; b) learn about associations between their stress and physical symptoms; and c) learn about the potential value of experiencing and expressing their emotions related to these stressful situations.
No Intervention: Wait-list Control
Standard medical care until the 6-week follow-up is completed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Symptom Interpretation Questionnaire (SIQ)
Time Frame: Change from baseline symptom attribution at 6-weeks
Change from baseline symptom attribution at 6-weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Patient Health Questionnaire-15 (PHQ-15)
Time Frame: Change from baseline in symptom severity at 6-weeks
Change from baseline in symptom severity at 6-weeks
Brief Pain Inventory (BPI)
Time Frame: Change from baseline pain at 6-weeks
Change from baseline pain at 6-weeks
Brief Symptom Inventory (BSI)
Time Frame: Change from baseline symptoms at 6-weeks
Change from baseline symptoms at 6-weeks
Insomnia Severity Scale (ISI)
Time Frame: Change from baseline insomnia at 6-weeks
Change from baseline insomnia at 6-weeks
Brief Fatigue Inventory
Time Frame: Change from baseline fatigue at 6-weeks
Change from baseline fatigue at 6-weeks
Satisfaction with Life Scale (SWLS)
Time Frame: Change from baseline life satisfaction at 6-weeks
Change from baseline life satisfaction at 6-weeks
Emotional Approach Coping Scale (EAC)
Time Frame: Change from baseline emotional approach coping at 6-weeks
Change from baseline emotional approach coping at 6-weeks
Emotional Processing Scale (EPS)
Time Frame: Change from baseline emotional processing at 6-weeks
Change from baseline emotional processing at 6-weeks
Inventory of Interpersonal Problems Scale (IIP-32)
Time Frame: Change from baseline interpersonal problems at 6-weeks
Change from baseline interpersonal problems at 6-weeks
Pain Catastrophizing Scale (PCS)
Time Frame: Change from baseline pain catastrophizing at 6-weeks
Change from baseline pain catastrophizing at 6-weeks
Change Assessment Questionnaire
Time Frame: Changes from baseline stage of change at 6-weeks
Changes from baseline stage of change at 6-weeks
McGill Pain Questionnaire (SF-MPQ-2)
Time Frame: Change from baseline pain at 6-weeks
Change from baseline pain at 6-weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

May 27, 2014

First Submitted That Met QC Criteria

May 27, 2014

First Posted (Estimate)

May 30, 2014

Study Record Updates

Last Update Posted (Estimate)

December 8, 2015

Last Update Submitted That Met QC Criteria

December 7, 2015

Last Verified

December 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Somatoform Disorders

Clinical Trials on Stress and Health Interview

3
Subscribe